Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.7350
-0.0350 (-4.55%)
Jun 19, 2026, 4:10 PM AEST
Orthocell Market Cap
Orthocell has a market cap or net worth of 200.11 million as of June 18, 2026. Its market cap has decreased by -38.52% in one year.
Market Cap
200.11M
Enterprise Value
156.25M
Revenue
9.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.74
Market Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 200.11M, an increase of 573.76%. That is a compound annual growth rate of 17.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 200.11M | -32.02% |
| Dec 31, 2025 | 294.37M | -9.37% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 300.53M |
| Starpharma Holdings | 294.80M |
| Recce Pharmaceuticals | 138.81M |
| Dimerix | 135.09M |
| Alterity Therapeutics | 130.50M |
| Actinogen Medical | 128.03M |
| Nyrada | 113.90M |
| LTR Pharma | 110.88M |